Cano Health, Inc.
CANO · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $2,738,916 | $1,609,369 | $831,576 | $361,384 |
| % Growth | 70.2% | 93.5% | 130.1% | – |
| Cost of Goods Sold | $2,317,223 | $1,410,400 | $666,345 | $284,672 |
| Gross Profit | $421,693 | $198,969 | $165,231 | $76,712 |
| % Margin | 15.4% | 12.4% | 19.9% | 21.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $394,243 | $252,133 | $103,962 | $59,148 |
| SG&A Expenses | $422,443 | $252,133 | $103,962 | $59,148 |
| Sales & Mktg Exp. | $28,200 | $0 | $0 | $0 |
| Other Operating Expenses | $90,640 | $49,441 | $18,499 | $6,822 |
| Operating Expenses | $513,083 | $301,574 | $122,461 | $65,970 |
| Operating Income | -$89,670 | -$102,605 | $42,640 | $10,811 |
| % Margin | -3.3% | -6.4% | 5.1% | 3% |
| Other Income/Exp. Net | -$336,562 | -$14,118 | -$113,053 | -$10,094 |
| Pre-Tax Income | -$426,232 | -$116,723 | -$70,413 | -$19,780 |
| Tax Expense | $2,157 | $14 | $651 | $9,913 |
| Net Income | -$428,389 | -$116,737 | -$71,064 | -$29,693 |
| % Margin | -15.6% | -7.3% | -8.5% | -8.2% |
| EPS | -87.6 | -24.54 | -42.75 | -17.86 |
| % Growth | -257% | 42.6% | -139.4% | – |
| EPS Diluted | -87.6 | -24.54 | -42.75 | -17.86 |
| Weighted Avg Shares Out | 4,890 | 4,757 | 1,662 | 1,662 |
| Weighted Avg Shares Out Dil | 4,890 | 4,757 | 1,662 | 1,662 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14 | $4 | $320 | $319 |
| Interest Expense | $62,495 | $51,291 | $34,002 | $10,163 |
| Depreciation & Amortization | $90,640 | $49,397 | $18,499 | $6,822 |
| EBITDA | -$197,616 | -$48,617 | -$18,042 | $17,633 |
| % Margin | -7.2% | -3% | -2.2% | 4.9% |